Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer
We identified some differentially expressed genes relevant to oncogenic signaling and immunosuppressive tumor-associated macrophages. These findings provide novel insights into factors affecting prognosis in patients with residual disease after NAC for early-stage TNBC.
Authors
- Der Sheng Sun (ORCID: https://orcid.org/0000-0003-0677-2098)
- Mihong Choi (ORCID: https://orcid.org/0000-0001-5576-7610)
- Sun‐Young Jun (ORCID: https://orcid.org/0000-0002-3007-2094)
- Hye Sung Won (ORCID: https://orcid.org/0000-0002-5134-4538)
- Kyung Jin Seo (ORCID: https://orcid.org/0000-0002-1908-9696)
- Yong-Seok Kim (ORCID: https://orcid.org/0000-0002-4676-4351)
- Jung‐Sook Yoon
- Jae Ho Byun (ORCID: https://orcid.org/0000-0001-8198-5507)
Institutions
- The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.3389/fonc.2025.1638758
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94